Vaccitech plc (VACC): Price and Financial Metrics

Vaccitech plc (VACC): $5.00

0.51 (+11.36%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add VACC to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#54 of 505

in industry

VACC Price/Volume Stats

Current price $5.00 52-week high $5.10
Prev. close $4.49 52-week low $1.64
Day low $4.28 Volume 165,300
Day high $5.10 Avg. volume 244,643
50-day MA $2.94 Dividend yield N/A
200-day MA $2.59 Market Cap 192.74M

VACC Stock Price Chart Interactive Chart >


Vaccitech plc (VACC) Company Bio


Vaccitech plc is a clinical-stage biopharmaceutical company that engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. Its therapeutic programs include VTP-300, indicated for the treatment of chronic hepatitis B infection; VTP-200, indicated for the treatment of human papilloma virus infection; VTP-850, indicated for the treatment of prostate cancer; and VTP-600, indicated for the treatment of non-small cell lung cancer. The company's prophylactic programs include VTP-400 for the prevention of herpes zoster or shingles; and VTP-500 for the prevention of Middle East respiratory syndrome. In addition, it is developing AZD1222, a COVID-19 vaccine. Vaccitech plc was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc on March 31, 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, United Kingdom.


VACC Latest News Stream


Event/Time News Detail
Loading, please wait...

VACC Latest Social Stream


Loading social stream, please wait...

View Full VACC Social Stream

VACC Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -59.71%
5-year N/A
YTD N/A
2023 0.00%
2022 -78.85%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!